Anti-Obesity Medications Could Soon Be Covered by Employers During Open Enrollment

Anti-obesity medications, including popular GLP-1 drugs like Wegovy, may soon be included in employer-covered health insurance plans, a shift that could significantly expand access to these treatments. As open enrollment season approaches, employees will have the chance to learn whether their health insurance benefits for the coming year will include coverage for these medications, which have surged in popularity due to their effectiveness in treating both diabetes and obesity.

While drugs like Wegovy are commonly covered under insurance plans for treating diabetes, coverage for their use in addressing obesity and weight loss has been far less common. . .